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Locked nucleic acids (LNAs) are modified nucleic acids which contain a
modified sugar such as -d-20-O,40-C methylene-bridged ribofuranose or other
sugar derivatives in LNA analogues. The -d-20-O,40-C methylene ribofuranose
LNAs in particular possess high stability and melting temperatures, which makes
them of interest for stabilizing the structure of different nucleic acids. Aptamers,
which are DNAs or RNAs targeted against specific ligands, are candidates for
substitution with LNAs in order to increase their stability. A 7-mer helix derived
from the terminal part of an aptamer that was targeted against ricin was chosen.
The ricin aptamer originally consisted of natural RNA building blocks and
showed high affinity in ricin binding. For future stabilization of the aptamer, the
terminal helix has been constructed as an ‘all-locked’ LNA and was successfully
crystallized in order to investigate its structural properties. Optimization of
crystal growth succeeded by the use of different metal salts as additives, such as
CuCl2, MgCl2, MnCl2, CaCl2, CoCl2 and ZnSO4. Preliminary X-ray diffraction
data were collected and processed to 2.8 Å resolution. The LNA crystallized in
space group P65, with unit-cell parameters a = 50.11, b = 50.11, c = 40.72 Å. The
crystals contained one LNA helix per asymmetric unit with a Matthews
coefficient of 3.17 Å3 Da1, which implies a solvent content of 70.15%.
1. Introduction
Aptamers are nucleic acids which are selected for specific target
binding from a large library by the recently developed ‘SELEX’
method (‘systematic evolution of ligands by exponential enrichment’;
Ellington & Szostak, 1990; Tuerk & Gold, 1990). The aptamers bind
the targets against which they are selected with high affinity and
selectivity, similar to the function of an antibody. However, aptamers
are much smaller in molecular mass than antibodies, which mostly lie
in the range 10–15 kDa (White et al., 2000). The therapeutical and
diagnostic potential of aptamers, as well as the binding properties of
aptamers to their ligands, have been investigated thoroughly and
reviewed extensively (Hermann & Patel, 2000; Nimjee et al., 2005;
Rimmele, 2003; Tombelli et al., 2005).
The first aptamer drug and the best example of their therapeutical
potential is the aptamer drug macugen, which acts as an endothelial
growth-factor antagonist in the therapy of neurovascular age-
dependent macular degeneration (Gryziewicz, 2005). Another
example is provided by the tenascin C-related tumour-marker
aptamer, which is undergoing clinical trials (Schmidt et al., 2004). The
selectivity and binding specificity of aptamers which were developed
against d-adenosine or against l-arginine have been demonstrated in
our laboratory (Klussmann et al., 1996; Nolte et al., 1996). In general,
aptamers show low or no immunogenicity and can in principle be
developed against arbitrary ligands; these facts open a broad field of
possible applications in diagnostic and therapeutic medicine.
Great interest is focused on the stabilization of aptamer tertiary
structures. A high in vitro stability for nucleic acids in general has
been achieved by the introduction of locked nucleic acid building
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blocks (LNAs), which were first synthesized in the institutes of T.
Imanishi (Obika et al., 1997) and J. Wengel (Kumar et al., 1998). The
‘LNA family’ consists of chemically synthesized nucleic acids with
modified sugar moieties, such as -d-20-O,40-C methylene cross-
linked ribofuranose. It has been generally proven that LNAs show
increased stability with respect to their melting behaviour, as could
also be demonstrated for the tenascin C-binding aptamer TTA-1 after
substitution with different modified nucleic acid blocks. With respect
to the thermal in vitro stability, the following order could be observed
for the melting temperature of the aptamer: 20-F/20-OMe < RNA/
RNA  20-OMe/20-OMe < 20-F/LNA < RNA/LNA < 20-OMe/LNA <
LNA/LNA (Schmidt et al., 2004). Enhanced thermostability in LNA-
substituted nucleic acids has been demonstrated in the laboratories of
P. Jacobsen and J. Wengel (Petersen et al., 2000). The studies showed
that the -d-20-O,40-C methylene ribofuranose ‘locks’ the LNA in the
C30-endo conformation, which influences the geometry of the phos-
phate backbone and orients the duplex in a manner that produces
more efficient base stacking (Obika et al., 1997; Petersen & Wengel,
2003). Intensive structural studies have been performed using
heteroduplexes such as -d- or -l-LNA/DNA mix-mers hybridized
to RNA or DNA. -d-LNA (LNA/DNA mix-mer)–RNA duplexes
adopt the A-type conformation, whereas -l-LNA (LNA/DNA mix-
mer)–DNA helices adopt the B-type conformation (Petersen et al.,
2002; Vester & Wengel, 2004). The NMR structures of a fully modi-
fied LNA hybridized to RNA or DNA showed the following:
generally, -d-LNA introduces the A-type nucleic acid conformation
into the duplexes, with the conformation in the -d-LNA–DNA
duplex being an equilibrium between N- and S-type sugar puckers
(Nielsen et al., 2004).
Here, we focus our interest on the RNA-based ricin aptamer which
was recently developed by Ellington and coworkers (Hesselberth et
al., 2000). A shortened aptamer named RA80.1.d1 (Fig. 1) was shown
to be fully biologically active. As we are generally interested in the
stabilization of different aptamers, we decided to take the anti-ricin
aptamer as a model substance for substitution with -d-20-O,40-C
methylene ribofuranose locked nucleic acids. We chose the terminal
stem of the RNA aptamer, which is indicated in Fig. 1, and it was
constructed as an ‘all-locked’ 7-mer duplex. By comparative crys-
tallization and X-ray structure analysis of the ‘all-LNA’ duplex and
the RNA counterpart, we hope to provide a basic structural com-
parison between the two helices which might help in investigating the
enhanced thermostability in LNA-substituted nucleic acids.
2. Materials and methods
2.1. Crystallization of the 7-mer LNA helix and measurement of
melting curves
The sequence of the LNA helix was derived from the terminal part
of the ricin aptamer, which was developed as an RNA molecule
(Hesselberth et al., 2000). The 7-mer helix in this study was designed
as an all-LNA and consists of nucleotide building blocks which
contain the -d-20-O,40-C methylene modified ribofuranose instead of
the natural ribose. Chemically synthesized nucleic acid oligonucleo-
tides with sequences 50-LNT-LNG-LNG-LNA-LNT-LNC-LNC-30
and 50-LNG-LNG-LNG-LNT-LNT-LNC-LNA-30 were purchased
from IBA (Göttingen, Germany) and were purified by HPLC by the
company. Both LNA strands were annealed in distilled water at a
concentration of 0.1 mM. The strands were combined and heated to
363 K for 5 min and subsequently cooled to room temperature for
several hours. The resulting LNA duplex was concentrated to 0.5 mM
in a speed vac (SpeedVac SC 110, Savant, Minnesota, USA) and used
in all subsequent crystallization experiments. For the measurement of
the melting curves of LNA versus RNA, RNA 7-mer oligonucleotides
with corresponding sequences were purchased from IBA (Göttingen,
Germany). The LNAs and RNAs were annealed and concentrated as
described above for the LNA crystallization experiments, while the
final concentration used for measuring the melting curves was
5.0 mM.
Initially, two different nucleic acid screening kits were used for
crystallization experiments. At first, the Natrix Nucleic Acid Crys-
tallization Kit (HR2-116; Hampton Research, California, USA),
which contains 48 different crystallization conditions, was used by
applying the sitting-drop vapour-diffusion technique with Crystal-
Quick Lp plates from Greiner Bio-One (Germany). 1 ml of a 0.5 mM
LNA solution in distilled water was mixed with 1 ml reservoir solution
and equilibrated against 80 ml reservoir solution at 294 K. Secondly,
the Nucleic Acid Mini Screen from Hampton Research (HR2-118)
with 24 different conditions was applied using the hanging-drop
vapour-diffusion technique and Linbro Plates (ICN Biomedicals Inc.,
Aurora, Ohio, USA). In this experiment, 1 ml of the 0.5 mM aqueous
LNA solution was mixed with 1 ml crystallization solution from the
screen and equilibrated against 1 ml reservoir solution which con-
tained 35%(v/v) 2-methyl-2,4-pentanediol (MPD) in distilled water
pH 7.4 at a temperature of 294 K.
Crystal optimization was performed using the hanging-drop
vapour-diffusion technique in Linbro Plates (ICN Biomedicals Inc.)
as described above. The basic conditions consisted of 50 mM sodium
cacodylate pH 6.0, 1.0 M lithium sulfate and 10 mM MgCl2. The
exchange of MgCl2 for CuCl2, MnCl2, CaCl2, CoCl2 or ZnSO4 led to
the final successful crystallization. The best crystal growth was
achieved using ZnSO4 as an additive instead of MgCl2.
In order to investigate the thermostability of the LNA compared
with the RNA duplex, we measured the melting curves of both the
LNA and RNA 7-mer helices. The melting curves were recorded on a
Hewlett Packard 8452A Diode Array spectrophotometer in 1.73 mM
disodium hydrogen phosphate, 1 mM potassium dihydrogen phos-
phate pH 7.2, 100 mM sodium chloride and 0.1 mM EDTA using a
concentration of 5.0 mM RNA or LNA. The OD260 was measured as a
function of temperature within the range 283–363 K with steps of 1 K
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Figure 1
The sequence of the RA80.1.d1 ricin aptamer derived from Hesselberth et al.
(2000). The box indicates the stem region which was designed as ‘all-locked’ nucleic
acid and investigated by X ray diffraction analysis.
increase per minute. The Tm values were obtained from the maxima
of the first derivatives of the melting curves.
2.2. Acquisition of the X-ray diffraction data and data processing
Prior to X-ray diffraction data collection, the crystals were flash-
frozen in a cryoprotectant solution containing 50 mM sodium caco-
dylate pH 6.0, 1 M lithium sulfate, 10 mM of the corresponding salt
listed above and 20%(v/v) glycerol.
The X-ray diffraction data were recorded on the DESY Synchro-
tron (Hamburg, Germany) consortium beamline X13 at a wavelength
of 0.8123 Å. A data set was recorded from 50 to 2.3 Å resolution at a
temperature of 100 K. The crystallographic data were analyzed and
processed to 2.8 Å resolution using programs from the HKL-2000
suite (Otwinowski & Minor, 1997). The solvent content of the crystals
was calculated by the method of Voss & Gerstein (2005), considering
the standard atomic values for RNA, assuming that the LNA packing
may be comparable with that of RNA.
To check for twinning, which is of common occurrence in RNA
crystals in our experience, the data sets were analyzed using the
Padilla and Yeates algorithm (Padilla & Yeates, 2003) as imple-
mented by the web server http://nihserver.mbi.ucla.edu/pystats. The
LNA data set showed a curve which corresponded to a theoretically
untwinned crystal, so we have no indication of merohedral twinning.
At present, molecular-replacement calculations are in progress
using an artificial LNA helix. The basis for the model was an LNA
duplex 7-mer structure that has been solved recently (unpublished
results) in which the sequence has been adapted to that of the present
LNA duplex from the ricin aptamer. The sugars in the model
corresponded to the LNA modifications; they were constructed as
-d-20-O,40-C methylene-bridged ribofuranoses. The program Phaser
(Read & Schierbeek, 1988) was used for the initial MR calculations
and REFMAC5 (Murshudov et al., 1997) was used for initial structure
refinement. Both programs were used as implemented in the CCP4i
package (Collaborative Computational Project, Number 4, 1994).
Coot was used for model building (Emsley & Cowtan, 2004).
3. Results and discussion
3.1. Crystallization
We are interested in the stabilization of aptamers by introducing
modified nucleic acids into the stem regions. As the order of thermo-
stability for modified nucleic acids is described to be 20-F/20-OMe <
crystallization communications
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Figure 2
Optimization of LNA crystal growth using different metal salts as an additive: (a) 10 mM MgCl2, (b) 10 mM CaCl2, (c) 10 mM CuCl2, (d) 10 mM ZnSO4. The basic conditions
in all setups consisted of 50 mM sodium cacodylate pH 6.0 and 1 M lithium sulfate. The crystals in (d) had approximate dimensions of 0.25  0.25  0.8 mm.
RNA/RNA  20-OMe/20-OMe < 20-F/LNA < RNA/LNA < 20-OMe/
LNA < LNA/LNA (Schmidt et al., 2004), we focused on introducing
LNA helices into the aptamer structures. As a first model, we
designed a stem region originating from the ricin aptamer (Hessel-
berth et al., 2000) as an ‘all-locked’ 7-mer -d-20-O,40-C methylene
ribofuranose LNA which contains exclusively locked nucleic acid
building blocks.
The LNA duplex (Fig. 1) initially crystallized in 50 mM sodium
cacodylate pH 6.0, 10 mM magnesium chloride, 1.0 M lithium sulfate
at 294 K after a few days. The small crystals had no clear morphology
and optimization of the precipitant and temperature was not
successful. By exchanging 10 mM MgCl2 for 10 mM MnCl2 or CaCl2,
the crystal morphology and size could be reproducibly influenced to a
great extent (Figs. 2a and 2b). This observation led to the idea to
further exchange the metal ion by using other heavy-metal salts as
additives. We further cocrystallized the LNA duplex with CuCl2,
CoCl2, NiCl2 or ZnSO4 (Figs. 2c and 2d) and observed a large
influence on crystal growth and crystal morphology depending on the
metal ion added in the setups. The best crystals were obtained with
ZnSO4 as an additive, with the final conditions being 50 mM sodium
cacodylate pH 6.0, 10 mM ZnSO4 and 1.0 M lithium sulfate at a
temperature of 294 K. The crystals appeared after several days and
had approximate dimensions of 0.25  0.25  0.8 mm (Fig. 2d).
3.2. Crystallographic data and Tm values
The 7-mer ‘all-LNA’ duplex crystallized in space group P65, with
one molecule in the asymmetric unit. The crystals with the best
morphology, which were grown using ZnSO4 as an additive, corre-
sponded to the crystals with the best crystallographic data; all other
crystals gave poor diffraction. A data set for the LNA crystal with
ZnSO4 was acquired in the resolution range 50–2.3 Å on the DESY
consortium beamline X13 (Hamburg, Germany) and the data were
processed to 2.8 Å resolution. The crystallographic parameters of the
all-LNA ricin-aptamer helix are listed in Table 1. From our data set,
we calculated a Matthews coefficient of 3.17 Å3 Da1 with one LNA
helix per asymmetric unit (Matthews, 1968). The solvent content of
70.2% seems high, but we have often observed solvent contents of
approximately 65–66% for RNA crystals (Förster, Brauer et al., 2007;
Förster, Perbandt et al., 2007). We can exclude the presence of a
second LNA helix in the asymmetric unit as this would imply a
Matthews coefficient of 1.58 Å3 Da1 and a solvent content of 40.1%.
Therefore, the crystals possess packing parameters with a relatively
high solvent content.
A possible structure solution of the LNA duplex was found by
molecular replacement using an artificial LNA as a model. A com-
parison of the -d-20-O,40-C methylene ribofuranose moiety of the
LNA with the natural ribose is shown in Fig. 3. Within the molecular-
replacement calculation, the translation function gave a Z score of 7.0
and the rotation function gave a Z score of 3.6. After initial refine-
ment calculations and the addition of solvent molecules, the R
values fell from R/Rfree = 50.3/48.9% to values in the region of
R/Rfree = 30/34%. It was on the basis of this likely structure solution
that we assigned the space group as P65. The nucleotide structures in
Fig. 3 are taken from an X-ray structure analysis of a tRNASer
microhelix, comparing that microhelix designed as RNA (Eichert et
al., 2009) with a preliminary one designed as LNA (unpublished
results) in our laboratory. The nucleic acid libraries in REFMAC
(Murshudov et al., 1997) consisted of either the standard RNA or
LNA descriptions. The nucleotides in Fig. 3 provide a basic com-
parison between RNA and LNA and show the -d-20-O,40-C
methylene cross-linked ribofuranose in LNAs.
Further refinement does not improve the R values at present and
we will therefore have to focus on improving the crystal quality. We
crystallization communications
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Table 1
Data-collection and processing statistics for the ‘all-LNA’ duplex originating from
the ricin aptamer RA80.1.d1 (Hesselberth et al., 2000).
The data correspond to the crystal grown with ZnSO4 as an additive; details are described
in the text. Values in parentheses are for the highest resolution shell.
Beamline DESY consortium beamline X13
Wavelength (Å) 0.8123
Space group P65
Unit-cell parameters (Å) a = 50.11, b = 50.11, c = 40.23
Matthews coefficient VM (Å
3 Da1) 3.17
LNA duplexes per ASU 1
Solvent content† (%) 70.15
Measured reflections 5223
Unique reflections 1371
Resolution range (Å) 50.0–2.80 (2.85–2.80)
Completeness (%) 93.1 (100.0)
Multiplicity 3.8 (4.0)
Rmerge‡ (%) 5.1 (14.5)
Average I/(I) 18.0 (1.2)
† As calculated using the method of Voss & Gerstein (2005). ‡ Rmerge =P
hkl
P




i IiðhklÞ, where Ii(hkl) and hI(hkl)i are the observed
individual and mean intensities of a reflection with indices hkl, respectively,
P
i is the sum
over the individual measurements of a reflection with indices hkl and
P
hkl is the sum
over all reflections.
Figure 3
The sugar moiety of the LNA helix investigated here is the -d-20-O,40-C methylene-bridged ribofuranose (a; the C atom of the methylene bridge is highlighted in black) and
is compared here with the natural ribose in RNA (b). The 20 and 30 sugar O atoms are marked in light blue and dark blue, respectively. Details of the origins of the nucleotides
are described in the text.
have noticed that the crystals are extremely sensitive to soaking in
cryoprotecting solution and to transportation. Immediate freezing of
the crystals in liquid nitrogen directly after their appearance might
help to further improve the quality of the X-ray diffraction data and
to calculate the final structure. Also, the addition of other metal ions
may further improve the crystal quality.
We measured the Tm values of the LNA duplex and the corre-
sponding RNA duplex to investigate the thermostability of the
helices. As described above, LNAs possess enhanced stability
compared with the unmodified RNA molecules. The LNA duplex
investigated here shows a Tm value of 357.4 K, whereas the RNA with
the corresponding sequence gives a value of Tm = 295.5 K.
With this work, we wish to contribute to the basic chemical
understanding of the enhanced thermostability of locked nucleic
acids. The crystal structure of an ‘all-locked’ -d-20-O,40-C methylene
ribofuranose LNA helix will contribute to the general understanding
of LNA conformation and stability. Additionally, we are highly
interested in techniques involving the application of LNAs. One
objective is the insertion of LNA duplexes into the stem regions of
aptamers that are designed against bioterrorism reagents such as
ricin, anthrax, vaccinia virus or botox. The introduction of LNA stem
regions should increase the stability of aptamers to a great extent by
leaving the biologically active RNA or DNA loop regions that
interact with the ligands unaffected. There are several reports in the
literature that describe the biological activity of LNA-substituted
nucleic acids. One example is the use of LNA modifications within
hammerhead ribozymes that improve the cleavage reaction (Chris-
tiansen et al., 2007). Another study involves the introduction of LNAs
into antisense oligonucleotides and DNAzymes that are targeted to
functionally selected binding sites and inhibit HIV-1 expression
(Jakobsen et al., 2007). LNAs have also been introduced into the G-
quadruplex thrombin aptamer, which retained its biological activity
to different extents depending on the nucleotide positions that were
modified (Bonifacio et al., 2008). These and other reports encourage
us to believe that the introduction of an LNA stem into the ricin
aptamer might not affect its function and that the ricin-binding
capacity might be maintained. At present, investigations are in
progress to examine the biological activity of the ricin aptamer after
introduction of LNA modifications into the stem region.
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